We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Fish & Richardson PC

Follow

Janssen Seeks Expedited Trial Following FDA Approval of Remicade Biosimilar

USA - April 14 2016 Biosimilar litigation and the implications of the BPCIA are continuing to unfold in light of the FDA's April 5, 2016 approval of Celltrion's

IPR Petitions in BioPharma Grow in Popularity

USA - April 13 2016 The popularity of IPR petitions in the biopharma space has steadily grown since 2012 when IPRs were first introduced as a means of challenging the

Celltrion Opposes Expedited Trial and Delayed Launch Date

USA - April 20 2016 On Monday, Celltrion filed a response to the letter Janssen submitted to the Court on April 12 requesting an expedited trial schedule. Celltrion

Ninth Circuit Issues Amended Opinion in “Dancing Baby” DMCA Notice-and-Takedown Case

USA - March 31 2016 Earlier this month the Ninth Circuit issued an amended opinion in the longstanding "Dancing Baby" notice-and-takedown case. The court added further

Using a DMCA takedown notice to assert a trademark claim may lead to section 512(f) liability

USA - March 26 2014 In 2011, Jenni Alvies launched a blog at "crossfitmamas.blogspot.com" and created a "CrossFit Mamas" Facebook page, where she posted exercise

Update on EU Unitary Patent and Unified Patent Court Developments - April 22, 2016

European Union, United Kingdom - April 22 2016 The UK vote on whether to leave the EU (Brexit) on June 23rd is probably the key to whether the Unified Patent Court (UPC) opens and the Unitary

EDTX denies Daubert motions involving apportionment, entire market value rule, license agreements, and patent valuations

USA - April 20 2016 The Eastern District of Texas, in Core Wireless Licensing SARL v. LG Electronics, Inc. et al, Case No. 2-14-cv-00911 (Judge Payne) (March 19, 2016

Celltrion Opposes Expedited Trial and Delayed Launch Date

USA - April 20 2016 On Monday, Celltrion filed a response to the letter Janssen submitted to the Court on April 12 requesting an expedited trial schedule. Celltrion

Janssen Seeks Expedited Trial Following FDA Approval of Remicade Biosimilar

USA - April 14 2016 Biosimilar litigation and the implications of the BPCIA are continuing to unfold in light of the FDA's April 5, 2016 approval of Celltrion's

IPR Petitions in BioPharma Grow in Popularity

USA - April 13 2016 The popularity of IPR petitions in the biopharma space has steadily grown since 2012 when IPRs were first introduced as a means of challenging the